Perspectives on human clinical trials of therapies using iPS cells in Japan: reaching the forefront of stem-cell therapies.
A research project involving sheets of retinal pigment epithelium constructed from iPS cells derived from patients with age-related maculopathy is one step closer to being approved for clinical trials by the Japanese Government. Now is the time to make therapies using iPS cells clinically available.